Skip to main content

Table 3 Assay conditions of each cysteine peptidase screened against the wild-type ppFhCL3, ppFhCL3 variants and synthetic peptide

From: Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed ‘clamp-like’ mechanism of binding and inhibition

Enzyme

Substrate

F. hepatica cathepsin L1

Z-Leu-Arg-NHMec (20 μM)

(FhCL1; 2.7 nM)

F. hepatica cathepsin L2

Z-Leu-Arg-NHMec (20 μM)

(FhCL2; 5 nM)

F. hepatica cathepsin L3

Z-Gly-Pro-Arg-NHMec (20 μM)

(FhCL3; 5 nM)

Human cathepsin L

Z-Phe-Arg-NHMec (20 μM)

(HsCL; 0.2 nM)

Human cathepsin K

Z-Phe-Arg-NHMec (20 μM)

(HsCK; 2 nM)